Jigang Ma

Title: Innovations of Jigang Ma in Cancer Treatment

Introduction

Jigang Ma is a notable inventor based in Dalian, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the synthesis and application of cyclin-dependent protein kinases (Cdks) inhibitors, which are crucial in the fight against cancer.

Latest Patents

Jigang Ma holds 1 patent related to his invention of a series of flavonoid organic amine derivatives that act as Cdks inhibitors. The patent describes a preparation method that involves using Baicalein or Wogonin as lead compounds, mixed with formaldehyde solution and organic amine compounds. The resulting product demonstrates a significant increase in activity, being 50 times more effective than Baicalin in inhibiting Cdks. This innovation selectively induces apoptosis in proliferative phase cancer cells while minimally affecting normal cells, positioning it as a promising anticancer drug.

Career Highlights

Throughout his career, Jigang Ma has focused on developing high-efficiency and low-toxicity drugs. His work emphasizes the importance of using readily available raw materials and simple processes to create effective treatments. The high purity and low cost of his products make them suitable for oral preparations or injections, potentially revolutionizing cancer and AIDS treatment.

Collaborations

Jigang Ma has collaborated with notable colleagues, including Shixuan Zhang and Yongming Bao. Their combined expertise has contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Jigang Ma's contributions to cancer treatment through his innovative patents highlight the potential of flavonoid organic amine derivatives as effective therapeutic agents. His work continues to inspire advancements in the field of oncology.